Discovery and clinical introduction of first-in-class imipridone ONC201.

In addition to highly significant activity against glioblastoma in vitro and in subcutaneous xenografts, a single dose of ONC201 was sufficient to double the survival of mice harboring aggressive intracranial human glioblastoma tumors [ 1 ].

also in 132,142 other papers